Update on the Phase 4 Confirmatory Study of ADUHELM®
Go back to Update on the Phase 4 Confirmatory Study of ADUHELM®| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 209.36 -0.47 (0.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $209.83 | 52 Week High | $333.65 | |||
| Open | $208.36 | 52 Week Low | $223.02 | |||
| Day High | $210.32 | P/E | 26.81 | |||
| Day Low | $207.62 | EPS | $7.81 | |||
| Volume | 248,270 | |||||

